Federal agents searched a peptide seller's address. Nobody has said it was about peptides.

On the morning of Wednesday 23 September 2026, federal agents searched a commercial building at 503 Prosperity Way in North Sioux City, South Dakota, and a house at 661 Prairie Boulevard in Dakota Dunes, a few miles away. KTIV, the local NBC affiliate, reported more than a dozen marked and unmarked vehicles arriving at the business around 10 a.m., agents carrying industrial clippers, evidence bags, totes and a U-Haul trailer, and the scene clearing shortly after 4 p.m. The search at the house was over before noon. The U.S. Postal Inspection Service is leading the investigation, out of Minneapolis, joined by the FBI's Omaha and Minneapolis offices, IRS Criminal Investigation, the Union County Sheriff's Office and North Sioux City Police. The building at 503 Prosperity Way is registered to Apex Waste Management, and it is the registered address of a cluster of other companies. One of them is Apex Peptides, which is a vendor in this site's price index.

KTIV followed up on 24 September with five more Apex-tied companies registered to 498 Prosperity Way, a building across the road that is still under construction, has no garage door and is not operating: Apex HC, LLC, registered on 15 September 2026; ApexTH&I, LLC, on 9 September 2026; Apex Health Club Holdings, LLC, on 26 August 2026; ApexRx Holdings, LLC, on 20 April 2026; and Apex Health Club, LLC, on 25 August 2026. Counting those, KTIV documents at least eleven registered Apex entities across four addresses in two states. KCAU 9, whose report we read as carried by Yahoo News, puts it higher, saying the South Dakota Secretary of State's register shows around two dozen businesses associated with Apex. Both outlets are reading the same register and we have not counted it ourselves, so we are giving you both numbers rather than picking one.

Now the part that matters more than any of it: what is known about why. Nothing. No charge has been filed, no criminal complaint or indictment has been made public, and no search-warrant affidavit has been unsealed. Investigators declined to say what they were looking for or what they took away. Nobody has been accused of anything by anyone. A search warrant means a judge was satisfied there was probable cause to look somewhere; it is not a finding that a crime was committed, and it is not even an allegation that the subject can contest, because no allegation has been made. Local reporting identifies individuals connected to the businesses. We are not repeating their names here, for exactly that reason — there is nothing yet for them to answer.

The version of this story circulating in peptide forums and on other vendors' blogs calls it an FDA raid. The FDA is not on the list of agencies. Neither is its Office of Criminal Investigations, which is the part of the agency that executes search warrants. The lead is the Postal Inspection Service, which, as KCAU 9 notes, enforces more than 200 federal laws covering crimes that use or affect the mail system, including illegal drugs and mail fraud. IRS Criminal Investigation works financial crime — unreported income, money laundering, structuring. A postal-and-tax pairing with the FBI assisting is the shape of a mail-and-money case. It may well turn out to concern peptides. It may equally concern any of the other businesses registered at that address, which between them cover waste management, outdoor goods, printing and embroidery, cosmetics, a health club and a pharmacy-sounding entity called ApexRx.

It is worth being concrete about what an FDA action against a peptide seller actually looks like, because we have described two this month and neither resembles this. On 18 September the agency issued warning letter 738238 to Empower Pharmacy; on 22 September it published warning letter 731846 to BioDrive, Inc. Both are public documents that name the products, quote the company's own words back at it, cite the sections of the Food, Drug and Cosmetic Act alleged to have been violated, and give the recipient fifteen working days to reply. That is the instrument, and its whole design is that you can read it. There is no such document here, and the absence of one cuts both ways: it is not evidence that Apex Peptides did anything wrong, and it is not evidence that it did not.

Our own index is where we can add something the local reporting cannot. Apex Peptides is one of 94 vendors we read. Our vendor page for it records 31 published listings, 24 of them matched into the price index with 7 still queued, last checked on 28 September 2026 and set to recheck every 24 hours. Across every vendor we track it is the cheapest on none of those 24 compounds and above typical on 22 of them — not a discounter, but one of the dearer sellers in the index. The catalogue we last read included NAD+ at 1000 mg, GHK-Cu at 50 mg, epithalon at 50 mg, semax at 30 mg, Melanotan II at 10 mg, GHRP-2, oxytocin, ipamorelin, MOTS-c, DSIP, AOD-9604, KPV, IGF-1 LR3 and follistatin-344 at 1 mg.

One row in it is worth naming on its own. The listing reads "GLP-1 S (5mg)", priced at $200.00, which our index normalises to $40.00 per milligram and flags as above typical against 28 other sellers. GLP-1 S is semaglutide. We wrote in August about that naming convention — twenty of the vendors we read had stopped printing the words semaglutide and tirzepatide anywhere on the page and moved to a house code instead. Whatever this investigation proves to be about, and it may be about nothing to do with any of this, the compound was being sold under a name chosen so that the compound's name does not appear.

We also checked the storefront ourselves rather than taking anyone's word for its state. As of today apexpeptides.com answers, with HTTP 200 and 535 bytes, and serves no catalogue at all. The page title is "Apex Peptides Login" and the body is a single line: "Maintanance | Technical break | Przerwa techniczna | Technischer bruch | Pause technique | Pausa tecnica | Descanso técnico | Pausa técnica | Технический перерыв | Teknik mola | 技术突破" — ten languages, with the English misspelled — served out of the site's own WordPress caching layer. That is a shop's maintenance mode, switched on from inside the shop. It is not a domain seizure, which normally serves a notice naming the seizing agency and the court that authorised it. KCAU 9 reported on 25 September that the site was showing as temporarily closed with all but one product removed, so it has been in some version of this state for several days.

Which leaves our own numbers needing a caveat we may as well state loudly. Every vendor page on this site carries the line that prices are what the vendor listed when we last looked and not a live quote. This is the case that line exists for: the 24 Apex listings in our index describe a catalogue that is not currently being served to anybody, and they carry the date we last read it. We would rather show you a dated figure and tell you the shop is dark than quietly drop the vendor and leave no trace that it was ever there.

Six things this does not establish, because all six are already being asserted somewhere. It is not a finding of wrongdoing against any person or company; nobody has been charged. It is not an FDA action. It is not established that the search had anything to do with peptides — no agency has said so, and the address hosts a great many businesses that sell other things. It is not a recall and it is not a safety finding: nothing has been alleged about the contents of any vial Apex Peptides shipped, and we have no testing of our own to offer. It has no connection to the July 2026 advisory committee recommendation on the 503A bulks list, or to the September warning letters we have covered, which involve different companies and different statutes. And we are not relying on the fullest accounts in circulation, which are a Substack post and several competing peptide vendors' blogs, some of which tie this to unrelated investigations in the same town; we could not verify those claims, and a rival seller's blog is not a source for what a federal search was about.